| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b4ee13af463c18c765406625e1c5d44 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0446
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0453 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04 |
| filingDate |
2018-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91efa9c127080c94743cbb4ff5034ab3 |
| publicationDate |
2019-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019113449-A1 |
| titleOfInvention |
In vivo imaging of tumor infiltration leukocytes |
| abstract |
The present invention is directed to the use of radiolabeled ligands of leukocyte function-associated antigen~1 (LFA~1 ) receptor in order to image and quantify leukocyte activation, recruitment and in vivo trafficking of tumor infiltrating lymphocytes. Diagnostic methods and methods of monitoring cancer therapy, including immunotherapy represent embodiments of the present invention. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110693864-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110693864-B |
| priorityDate |
2017-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |